These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3390288)

  • 21. Prognostic importance of the DNA ploidy pattern in malignant mesothelioma of the pleura.
    Dejmek A; Strömberg C; Wikström B; Hjerpe A
    Anal Quant Cytol Histol; 1992 Jun; 14(3):217-21. PubMed ID: 1418271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Scoring system for differential diagnosis of malignant mesothelioma and reactive mesothelial cells on cytology specimens.
    Kimura N; Dota K; Araya Y; Ishidate T; Ishizaka M
    Diagn Cytopathol; 2009 Dec; 37(12):885-90. PubMed ID: 19572412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The significance of morphometric methods in cytologic diagnostics: differentiation between mesothelial cells, mesothelioma cells and metastatic adenocarcinoma cells in pleural effusions with special emphasis on chromatin texture.
    Oberholzer M; Ettlin R; Christen H; Gschwind R; Buser M; Rösel F; Lötscher R; Dalquen P
    Anal Cell Pathol; 1991 Jan; 3(1):25-42. PubMed ID: 2001333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long microvilli of mesothelioma are conspicuous in pleural effusions processed by Ultrafast Papanicolaou stain.
    Yang GC
    Cancer; 2003 Feb; 99(1):17-22. PubMed ID: 12589641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. UHRF1 Immunohistochemical Staining Separates Benign Reactive Spindle Cell Mesothelial Proliferations From Sarcomatoid Mesotheliomas.
    Yang H; Cheung S; Churg A
    Am J Surg Pathol; 2022 Jun; 46(6):840-845. PubMed ID: 34772842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wilms tumor 1/cytokeratin dual-color immunostaining reveals distinctive staining patterns in metastatic melanoma, metastatic carcinoma, and mesothelial cells in pleural fluids: an effective first-line test for the workup of malignant effusions.
    Conner JR; Cibas ES; Hornick JL; Qian X
    Cancer Cytopathol; 2014 Aug; 122(8):586-95. PubMed ID: 25044880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation and prognostic value of DNA content and of morphometric parameters in malignant mesothelioma using digital image analysis.
    Segers K; Singh SK; Van Daele A; Bogers J; Van Meerbeeck J; Vermeire P; Weyler J; Van Marck E
    Lung Cancer; 1996 Jun; 14(2-3):229-37. PubMed ID: 8794406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry.
    Su XY; Li GD; Liu WP; Xie B; Jiang YH
    Diagn Cytopathol; 2011 Dec; 39(12):900-8. PubMed ID: 20836004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Utility of morphometry and nucleolar organizer regions count in the differentiation of reactive and malignant mesothelial cells in pleural effusions].
    Colecchia M; Agnelli T; Caronni E; Leopardi O
    Pathologica; 1991; 83(1083):89-97. PubMed ID: 1866205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The diagnostic utility of D2-40, calretinin, CK5/6, desmin and MOC-31 in the differentiation of mesothelioma from adenocarcinoma in pleural effusion cytology.
    Hyun TS; Barnes M; Tabatabai ZL
    Acta Cytol; 2012; 56(5):527-32. PubMed ID: 23075894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA flow cytometry of pleural effusions. Comparison with pathology for the diagnosis of malignancy.
    Evans DA; Thornthwaite JT; Ng AB; Sugarbaker EV
    Anal Quant Cytol; 1983 Mar; 5(1):19-27. PubMed ID: 6846965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cytophotometric analysis on DNA alteration of mesothelial cells in malignant and non-malignant effusions (author's transl)].
    Isoda K; Sobajima T; Hamamoto Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1982 Feb; 20(2):159-63. PubMed ID: 7098179
    [No Abstract]   [Full Text] [Related]  

  • 33. Differentiation of mesothelioma from adenocarcinoma in serous effusions: the role of hyaluronic acid and CD44 localization.
    Afify AM; Stern R; Michael CW
    Diagn Cytopathol; 2005 Mar; 32(3):145-50. PubMed ID: 15690337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Static DNA cytometry as a diagnostic aid in effusion cytology: II. DNA aneuploidy for identification of neoplastic cells in equivocal effusions.
    Motherby H; Nadjari B; Remmerbach T; Marcy T; Pomjanskaja N; Müller W; Knops K; Häussinger D; Strauer BE; Böcking A
    Anal Quant Cytol Histol; 1998 Jun; 20(3):162-8. PubMed ID: 9642442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential diagnosis of reactive mesothelial cells and malignant mesothelioma cells using the cell proliferation markers minichromosome maintenance protein 7, geminin, topoisomerase II alpha and Ki-67.
    Kimura F; Okayasu I; Kakinuma H; Satoh Y; Kuwao S; Saegusa M; Watanabe J
    Acta Cytol; 2013; 57(4):384-90. PubMed ID: 23860238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MUC4 is upregulated in ovarian carcinoma effusions and differentiates carcinoma cells from mesothelial cells.
    Davidson B; Baekelandt M; Shih IeM
    Diagn Cytopathol; 2007 Dec; 35(12):756-60. PubMed ID: 18008338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of PCNA in differentiating between malignant mesothelioma and mesothelial hyperplasia: prognostic considerations.
    Esposito V; Baldi A; De Luca A; Paciocco G; Gröger A; Sgaramella G; Claudio PP; Giordano GG; Baldi F; Caputi M; Kaiser H; Giordano A
    Anticancer Res; 1997; 17(1B):601-4. PubMed ID: 9066586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effusion cytology in the diagnosis of malignant epithelioid and biphasic pleural mesothelioma.
    Sherman ME; Mark EJ
    Arch Pathol Lab Med; 1990 Aug; 114(8):845-51. PubMed ID: 2375659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transforming growth factor alpha and epidermal growth factor receptor in reactive and malignant mesothelial proliferations.
    Cai YC; Roggli V; Mark E; Cagle PT; Fraire AE
    Arch Pathol Lab Med; 2004 Jan; 128(1):68-70. PubMed ID: 14692808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic utility of D2-40 and podoplanin in effusion cell blocks.
    Bhalla R; Siddiqui MT; Mandich D; Cartun RW; Fiel-Gan MD; Nassar A; Mandavilli SR
    Diagn Cytopathol; 2007 Jun; 35(6):342-7. PubMed ID: 17497664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.